These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7685764)

  • 1. Loop substitution as a tool to identify active sites of interleukin-1 beta.
    Palla E; Bensi G; Solito E; Buonamassa DT; Fassina G; Raugei G; Spano F; Galeotti C; Mora M; Domenighini M
    J Biol Chem; 1993 Jun; 268(18):13486-92. PubMed ID: 7685764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra-like domains.
    Boraschi D; Bossù P; Ruggiero P; Tagliabue A; Bertini R; Macchia G; Gasbarro C; Pellegrini L; Melillo G; Ulisse E; Visconti U; Bizzarri C; Del Grosso E; Mackay AR; Frascotti G; Frigerio F; Grifantini R; Grandi G
    J Immunol; 1995 Nov; 155(10):4719-25. PubMed ID: 7594472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic alleles at position 121 define a functional domain of human interleukin-1 beta.
    Ambrosetti DC; Palla E; Mirtella A; Galeotti C; Solito E; Navarra P; Parente L; Melli M
    Eur J Biochem; 1996 Jun; 238(2):308-16. PubMed ID: 8681939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A search within the IL-1 type I receptor reveals a peptide with hydropathic complementarity to the IL-1beta trigger loop which binds to IL-1 and inhibits in vitro responses.
    Heal JR; Bino S; Ray KP; Christie G; Miller AD; Raynes JG
    Mol Immunol; 1999 Dec; 36(17):1141-8. PubMed ID: 10698316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of interactive sites of proteins and protein receptors by computer-assisted searches for complementary peptide sequences.
    Fassina G; Melli M
    Immunomethods; 1994 Oct; 5(2):114-20. PubMed ID: 7874435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1 beta by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1 beta.
    Evans RJ; Bray J; Childs JD; Vigers GP; Brandhuber BJ; Skalicky JJ; Thompson RC; Eisenberg SP
    J Biol Chem; 1995 May; 270(19):11477-83. PubMed ID: 7744786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion mutants of human interleukin 1 beta with significantly reduced agonist properties: search for the agonist/antagonist switch in ligands to the interleukin 1 receptors.
    Simoncsits A; Bristulf J; Tjörnhammar ML; Cserzö M; Pongor S; Rybakina E; Gatti S; Bartfai T
    Cytokine; 1994 Mar; 6(2):206-14. PubMed ID: 8032002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of neutralizing epitopes and the receptor binding site of human interleukin 1 beta.
    Simon PL; Kumar V; Lillquist JS; Bhatnagar P; Einstein R; Lee J; Porter T; Green D; Sathe G; Young PR
    J Biol Chem; 1993 May; 268(13):9771-9. PubMed ID: 7683661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor.
    Labriola-Tompkins E; Chandran C; Kaffka KL; Biondi D; Graves BJ; Hatada M; Madison VS; Karas J; Kilian PL; Ju G
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11182-6. PubMed ID: 1837145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mutational analysis of receptor binding sites of interleukin-1 beta: differences in binding of human interleukin-1 beta muteins to human and mouse receptors.
    Grütter MG; van Oostrum J; Priestle JP; Edelmann E; Joss U; Feige U; Vosbeck K; Schmitz A
    Protein Eng; 1994 May; 7(5):663-71. PubMed ID: 8073036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An antibody to a 17 amino acid synthetic peptide of the type I interleukin-1 receptor preferentially blocks interleukin-1 beta binding.
    Clark BD; Ikejima T; Mancilla J; Orencole SF; Sirko SP; Ishii N; Okuda K; Dinarello CA
    J Interferon Cytokine Res; 1996 Dec; 16(12):1079-88. PubMed ID: 8974012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist.
    Symons JA; Young PR; Duff GW
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1714-8. PubMed ID: 7878046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual expression of p80 type I and p68 type II interleukin-I receptors on anterior pituitary cells synthesizing growth hormone.
    French RA; Zachary JF; Dantzer R; Frawley LS; Chizzonite R; Parnet P; Kelley KW
    Endocrinology; 1996 Sep; 137(9):4027-36. PubMed ID: 8756580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of critical regions within the TIR domain of IL-1 receptor type I.
    Radons J; Falk W; Dove S
    Int J Biochem Cell Biol; 2015 Nov; 68():15-20. PubMed ID: 26279140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of intracellular interleukin-1 beta signals via type II interleukin-1 receptor in human gingival fibroblasts.
    Chou HH; Takashiba S; Maeda H; Naruishi K; Nishimura F; Arai H; Lu H; Murayama Y
    J Dent Res; 2000 Sep; 79(9):1683-8. PubMed ID: 11023264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-10 and IL-4 regulate type-I and type-II IL-1 receptors expression on IL-1 beta-activated mouse primary astrocytes.
    Pousset F; Cremona S; Dantzer R; Kelley KW; Parnet P
    J Neurochem; 2001 Nov; 79(4):726-36. PubMed ID: 11723165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of type I IL-1 beta receptor fragment 151-162 to interleukin-1 beta.
    Fasina G; Verdoliva A; Cassani G; Melli M
    Growth Factors; 1994; 10(2):99-106. PubMed ID: 8068354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-directed mutagenesis--molecular biology and rational drug design.
    Ju G; Labriola-Tompkins E; Varnell T; Madison V; Graves B
    Agents Actions Suppl; 1995; 47():155-9. PubMed ID: 7785490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function analysis of human IL-1 alpha: identification of residues required for binding to the human type I IL-1 receptor.
    Labriola-Tompkins E; Chandran C; Varnell TA; Madison VS; Ju G
    Protein Eng; 1993 Jul; 6(5):535-9. PubMed ID: 7692435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The membrane form of the type II IL-1 receptor accounts for inhibitory function.
    Neumann D; Kollewe C; Martin MU; Boraschi D
    J Immunol; 2000 Sep; 165(6):3350-7. PubMed ID: 10975853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.